GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-8.5%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$145M
AUM Growth
+$145M
(-28%)
Cap. Flow
-$34.6M
Cap. Flow
% of AUM
-23.79%
Top 10 Holdings %
Top 10 Hldgs %
57.57%
Holding
46
New
5
Increased
10
Reduced
10
Closed
15
Top Buys
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$10.4M |
| 2 |
Celldex Therapeutics
CLDX
|
$10.2M |
| 3 |
Cogent Biosciences
COGT
|
$7.22M |
| 4 |
Ascendis Pharma
ASND
|
$6.04M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$4.39M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $10.7M | 5.59% | 1,000,000 -100,000 | -9% | -$1.07M |
|
2
Apellis Pharmaceuticals
APLS
$3.48B
| $10.2M | 5.3% | 225,000 -25,000 | -10% | -$1.13M |
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $9.75M | 5.08% | 130,000 +80,000 | +160% | +$6M |
|
4
Axsome Therapeutics
AXSM
$6.05B
| $8.62M | 4.49% | 225,000 +130,500 | +138% | +$5M |
|
|
5
Cogent Biosciences
COGT
$1.69B
| $8.12M | 4.23% | 900,000 -800,000 | -47% | -$7.22M |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.98M | 4.15% | +100,000 | New | +$7.98M |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.38M | 3.85% | 110,000 +90,000 | +450% | +$6.04M |
|
8
Vaxcyte
PCVX
$4B
| $7.07M | 3.68% | 325,000 +25,000 | +8% | +$544K |
|
|
9
Ascendis Pharma
ASND
$11.8B
| $6.97M | 3.63% | 75,000 -65,000 | -46% | -$6.04M |
|
10
Viridian Therapeutics
VRDN
$1.5B
| $6.94M | 3.62% | 600,000 +133,597 | +29% | +$1.55M |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.19M | 3.23% | +35,000 | New | +$6.19M |
|
|
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.69M | 2.97% | 45,000 -15,000 | -25% | -$1.9M |
|
13
Merus
MRUS
$4.98B
| $5.66M | 2.95% | 250,000 -150,000 | -38% | -$3.4M |
|
|
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.81M | 2.51% | 500,000 +50,000 | +11% | +$481K |
|
|
CTIC
15
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $4.78M | 2.49% | 800,000 -500,000 | -38% | -$2.99M |
|
16
Relmada Therapeutics
RLMD
$37.2M
| $4.75M | 2.47% | 250,000 +150,000 | +150% | +$2.85M |
|
17
Arvinas
ARVN
$568M
| $4.63M | 2.41% | 110,000 | – | – |
|
18
Syndax Pharmaceuticals
SNDX
$1.41B
| $4.33M | 2.25% | 225,000 | – | – |
|
19
Design Therapeutics
DSGN
$315M
| $3.85M | 2.01% | 275,000 +75,000 | +38% | +$1.05M |
|
20
Kezar Life Sciences
KZR
$28.9M
| $3.72M | 1.94% | 450,000 +50,000 | +13% | +$414K |
|
21
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.44M | 1.79% | 325,000 -25,000 | -7% | -$265K |
|
22
RAPT Therapeutics
RAPT
$188M
| $3.01M | 1.57% | 165,000 -85,000 | -34% | -$1.55M |
|
|
WHWK
23
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $1.85M | 0.96% | 150,000 | – | – |
|
24
Tarsus Pharmaceuticals
TARS
$2.47B
| $1.75M | 0.91% | 120,000 | – | – |
|
25
MoonLake Immunotherapeutics
MLTX
$3.54B
| $1.58M | 0.82% | +300,000 | New | +$1.58M |
|